Vaccination or in vitro activation of CTLs resulted in CTL clones that specifically recognized hTERT540–548/HLA-A*02:01; nevertheless, results concerning the clones’ ability to lyse hTERT-expressing tumor cell lines are conflicting. Here, HLA-A is linked to neoplasm.